Rare diseases
Investigational molecules
Locations
Study on the Effects and Safety of Prasinezumab for Patients with Early Parkinson's Disease
LuxembourgStudy on the Safety and Effectiveness of IMGN151 for Women with Recurrent Endometrial and Ovarian Cancer
LuxembourgStudy on the Effects and Safety of Camizestrant (AZD9833) Compared to Fulvestrant in Postmenopausal Women with Advanced ER-Positive HER2-Negative Breast Cancer
LuxembourgStudy on DF1001, Nivolumab, and Paclitaxel for Patients with Advanced Solid Tumors
LuxembourgStudy of SBP-101, Nab-Paclitaxel, and Gemcitabine for Patients with Metastatic Pancreatic Cancer
LuxembourgStudy of Eftilagimod Alpha and Paclitaxel in Patients with HER2-Negative/Low Metastatic Breast Cancer
LuxembourgStudy of ribociclib combined with hormone therapy for patients with early-stage hormone receptor-positive, HER2-negative breast cancer
LuxembourgStudy on Baricitinib for Hospitalized Patients with Severe or Critical COVID-19
LuxembourgStudy on the Effectiveness and Safety of Bemcentinib for Hospitalized Patients with Moderate COVID-19
LuxembourgStudy on the Safety and Effectiveness of Magrolimab with Bevacizumab and Drug Combination for Patients with Advanced Metastatic Colorectal Cancer
LuxembourgStudy on Aspirin for Preventing Recurrence and Improving Survival in Patients with Resected Colon Cancer
LuxembourgStudy on Treatment for Recurrent Platinum-Sensitive Ovarian, Peritoneal, or Fallopian Tube Cancer Using Carboplatin and Mirvetuximab Soravtansine in Eligible Patients
LuxembourgTell us about your condition – we search every trial in Europe and connect you with the right site.
